Clinical trial
A Randomized Controlled Trial to Evaluate the Efficacy, Acceptability and Safety of Event-driven Pre-exposure Prophylaxis for HIV Using TAF/FTC in Men Who Have Sex With Men in Thailand and France
NCT05813964 is registered in ClinicalTrials.gov with ANRS, Emerging Infectious Diseases as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized Controlled Trial to Evaluate the Efficacy, Acceptability and Safety of Event-driven Pre-exposure Prophylaxis for HIV Using TAF/FTC in Men Who Have Sex With Men in Thailand and France
- Lead sponsor
- ANRS, Emerging Infectious Diseases
- Phase
- Phase 3
- Overall status
- Recruiting
- Start date
- June 5, 2024
- Completion date
- May 31, 2028
- Enrollment
- 524 (estimated)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.
hiv/aids